Skip to main content
ACS Pharmacology & Translational Science logoLink to ACS Pharmacology & Translational Science
. 2024 Sep 17;7(10):3096–3107. doi: 10.1021/acsptsci.4c00293

Determination of Protein–Ligand Binding Affinities by Thermal Shift Assay

Mohammad F Khan †,*, Mohammad M Rahman , Yue Xin , Abdur Mustafa , Brian J Smith §, Karen M Ottemann , Anna Roujeinikova †,⊥,*
PMCID: PMC11487536  PMID: 39430314

Abstract

graphic file with name pt4c00293_0006.jpg

Quantification of protein–ligand interactions is crucial for understanding the protein’s biological function and for drug discovery. In this study, we employed three distinct approaches for determination of protein–ligand binding affinities by a thermal shift assay using a single ligand concentration. We present the results of the comparison of the performance of the conventional curve fitting (CF) method and two newly introduced methods - assuming zero heat capacity change across small temperature ranges (ZHC) and utilizing the unfolding equilibrium constant (UEC); the latter has the advantage of reducing calculations by obtaining the unfolding equilibrium constant directly from the experimental data. Our results highlight superior performance of the ZHC and UEC methods over the conventional CF method in estimating the binding affinity, irrespective of the ligand concentration. In addition, we evaluated how the new methods can be applied to high-throughput screening for potential binders, when the enthalpy (ΔHL) and molar heat capacity change (ΔCPL) of ligand binding are unknown. Our results suggest that, in this scenario, using the −300 cal K–1 mol–1 assumption for ΔCpL and either −5 kcal mol–1 or the average enthalpy efficiency-based estimation for ΔHL(T) can still provide reasonable estimates of the binding affinity. Incorporating the new methods into the workflow for screening of small drug-like molecules, typically conducted using single-concentration libraries, could greatly simplify and streamline the drug discovery process.

Keywords: thermal shift assay, protein unfolding, melting temperature, unfolding equilibrium, binding affinity


Proteins rarely function in isolation: virtually all biological processes mediated by proteins, from signal transduction to cellular regulation and immune responses, involve direct interactions with other molecules.1,2 Therefore, the development of robust methods to accurately determine protein–ligand binding affinities is crucial for advancing drug discovery and therapeutic development.3 Traditional techniques such as isothermal titration calorimetry (ITC) or surface plasmon resonance (SPR), while accurate, are resource-intensive and not suitable for high-throughput screening. Therefore, there is a high demand for methods that can accurately determine binding affinities in a high-throughput screening manner.

Among experimental techniques employed to study protein–ligand interactions, a thermal shift assay (TSA), also known as differential scanning fluorimetry (DSF) or ThermoFluor, is emerging as a cost-effective, rapid, high-throughput screening technique for identifying protein ligands.4,5 The method is based on the phenomenon of ligand-mediated protein stabilization against thermal denaturation, that arises from the energetic coupling of ligand binding and protein unfolding.4,6 TSA has been widely used for buffer optimization to increase protein stability (important for crystallization, or design of vaccine- or antibody-based therapies), including identification of small molecules that increase protein stability by specifically binding to it (used in drug discovery).7,8 It is now increasingly recognized that TSA can also be used to determine the binding affinity (Kd) of a protein–ligand interaction.911 The energetic relationship between ligand binding and protein unfolding leads to ligand-dependent changes in the unfolding transition temperature (ΔTm) of a protein, and this dependency can be used to determine the binding affinity of the ligand.4,6

Determination of protein–ligand binding affinities by TSA offers many advantages over other methods, particularly where high affinity interactions are concerned.11,12 ITC, SPR, and stopped-flow assay of inhibition of enzymatic activity (SFA) have inherent limitations in measuring high-affinity binding.11 In the case of ITC, for example, tight binding with an affinity in the picomolar range can only be quantified by performing competitive displacement experiments.13 Other significant advantages of TSA over ITC include the ability to measure protein–ligand interactions that are driven by entropy, or when the ligand has a high heat of dilution. Although NMR is another attractive technique for characterizing protein–ligand interactions, it is cost-intensive, limited to relatively weak affinities (above the low micromolar range), requires large protein concentrations, and lacks the throughput of TSA.14 Fluorescence polarization/anisotropy technique requires a significant mass difference between the protein and ligand, along with the covalent attachment of a fluorescent label to the ligand, which also limits experimental throughput.15,16

Although the potential of TSA for determining binding affinities is well recognized, the existing methods described in the literature require a set of measurements for a range of different ligand concentrations.911 The requirement for a greater amount of ligand and increased experimental time means the existing methods cannot be easily translated into high-throughput drug screening applications. In this study, we addressed this problem and developed an approach that can use data for a single ligand concentration, significantly simplifying the determination of binding affinity from TSA.

Here, we compared three distinct approaches for TSA-based protein–ligand affinity measurements, 1) curve fitting (CF), 2) assuming zero heat capacity change across small temperature ranges (ZHC), and 3) utilizing knowledge of the unfolding equilibrium constant (UEC). We evaluated these approaches for several different receptor–ligand pairs by comparing the TSA-derived binding affinities, calculated over a range of ligand concentrations, with the values obtained using ITC - a technique that is often considered a golden standard for measuring Kd. The receptors used in this study were bacterial proteins dipeptide permease protein A (DppA) from Helicobacter pylori and sensing domains of chemoreceptors transducer-like protein 3 (Tlp3) from Campylobacter jejuni, chemotactic transducer of amino acids type A (CtaA) from Pseudomonas fluorescens and transducer-like protein C (TlpC) from H. pylori.1721

Our results revealed that the CF approach, that, up to date, has been widely used to estimate Kd from TSA data,4,6,22 yields values that not only significantly deviate from the values determined using ITC, but are also strongly dependent on ligand concentration, the latter finding being consistent with the previous reports.4 In contrast, both the ZHC and UEC methods introduced in this work demonstrated good agreement with ITC irrespective of the ligand concentration used in the TSA. The novel approaches described herein enable accurate determination of binding affinity from TSA data collected for a single ligand concentration. Implementation of these methods for screening of small drug-like molecules, that is typically performed using libraries of molecules at one fixed concentration, would significantly enhance and streamline the drug discovery workflow. It is important to recognize that the methods developed here were tested on a set of ligands with limited chemical diversity. Therefore, to fully validate and extend the applicability of our approach, further experimental studies with ligands of varying chemical properties are necessary.

Materials and Methods

Protein Purification and Thermal Shift Assays

The proteins were overexpressed in Escherichia coli and isolated to >98% purity as described previously.21,2325 Stock solutions of ligands were prepared in the same buffers as the corresponding proteins. The thermal shift assays (TSAs) were performed in triplicates, in a 25 μL final volume of mixture containing 5 μM or 10 μM of protein in the appropriate buffer, 10× SYPRO Orange and varying concentrations of ligand. The samples were heated from 35 to 85 °C with a ramp rate of 0.5 °C min–1, and protein unfolding was monitored by following the SYPRO Orange fluorescence (excitation/emission 530 nm/555 nm) using a Rotor-Gene Q real-time PCR cycler (Qiagen). All the measurements were performed in triplicate and the values are presented as mean ± SD.

TSAs of the sensing domain of C. jejuni Tlp3 (10 μM) were carried out in a buffer containing 100 mM Tris-HCl pH 8.0 and 150 mM NaCl. Ligands were added at 3 mM (L-isoleucine, L-leucine, L-norvaline (Nva)), or 10 mM (L-valine) concentration. To assess the ligand-concentration-dependent variability of the calculated binding affinities, the assay with Ile was repeated at nine different concentrations ranging from 0.1 mM (∼1 Kd (determined previously using ITC)18) to 20 mM (receptor-saturating concentration).

TSAs of the sensing domain of P. fluorescens CtaA (5 μM) were carried out in a buffer containing 100 mM sodium citrate pH 5.5 and 200 mM NaCl. Ligands (L-valine, L-alanine, L-serine or L-leucine) were added at 20 μM concentration. To assess the ligand-concentration-dependent variability of the calculated binding affinities, the assay with Ser was repeated at seven different concentrations ranging from 10 μM to 70 μM (∼1 Kd (determined previously using ITC)19 to ∼7.5 Kd (receptor-saturating concentration)).

TSA of the sensing domain of H. pylori TlpC (20 μM) was carried out with or without 7.5 mM L-lactate in a buffer containing 100 mM HEPES pH 7.0 and 250 mM NaCl. TSA of H. pylori DppA (10 μM) was performed with or without its ligand, tetrapeptide Ser-Thr-Ser-Ala (STSA) (200 μM), in a buffer solution containing 100 mM Tris pH 8.0 and 150 mM NaCl.

Thermal Shift Assay Data Analysis Approaches

In the methods that follow, it is assumed that protein unfolding occurs as a two-state transition state, and the ligand only binds the folded form and stabilizes it.

Curve Fitting (CF) Method

In TSA, as a protein starts to unfold upon heating, interaction between the SYPRO Orange dye and exposed hydrophobic residues leads to a sigmoidal increase in the fluorescence intensity. As the temperature rises, the fluorescence intensity eventually reaches the plateau and then decreases due to aggregation of the denatured protein-dye complexes.4 Data points collected after the plateau were excluded, and the sigmoidal part of the unfolding curve was fit (using GraphPad Prism 7.02) to the following equation to determine ΔHu(To), ΔCpu(To) and To by nonlinear regression:4,6

graphic file with name pt4c00293_m001.jpg 1

where F(T) is the fluorescence intensity at temperature T, To is the temperature at the midpoint of the protein unfolding transition in the absence of ligand (also known as the protein’s melting temperature), Fmin and Fmax are the pre- and post-transitional fluorescence intensities, respectively, R is the molar gas constant (1.987 cal K–1 mol–1), ΔHu(To) is the enthalpy of protein unfolding in the absence of ligand, and ΔCpu(To) is the molar heat capacity change on protein unfolding in the absence of ligand.

Since the melting temperature of the protein in the presence of a ligand (Tm) cannot be accurately and reliably estimated using eq 1(4,6) due to the presence of multiple unknowns, we calculated Tm by fitting the sigmoidal portion of the fluorescence intensity data to the Boltzmann sigmoid equation:

graphic file with name pt4c00293_m002.jpg 2

where δ is the slope of the fluorescence intensity data.

The calculated values of Hu(To), ΔCpu(To), To and Tm were then used to calculate the ligand binding affinity in terms of dissociation constant at Tm (Kd(Tm)) using the following equation:12

graphic file with name pt4c00293_m003.jpg 3

where [L]Tm is free ligand concentration at Tm. The following approximations can be made: [L]Tm=[L]total/2 when [L]total<[P]total; [L]Tm=[L]total–[P]total/2 when [L]total ≥ [P]total;12 and [L]Tm ≈ [L]total when [L]total ≫ [P]total.6

Zero Heat Capacity Change (ZHC) Method

In this method, the enthalpy of unfolding (ΔHu(To)) in the absence of ligand was calculated by following the method described by Wright et al. 2017.26 The Fmin and Fmax were obtained from the nonlinear least-squares fitting of the fluorescence data using eq 2. The fraction of protein unfolded (Qu), folded (Qf) and the equilibrium constant of unfolding (Ku) in the absence of ligand were calculated at each temperature (T) using eqs 4, (5) and (6), respectively.

graphic file with name pt4c00293_m004.jpg 4
graphic file with name pt4c00293_m005.jpg 5
graphic file with name pt4c00293_m006.jpg 6

The Gibbs free energy of unfolding (ΔGu(T)) for each temperature was then calculated using the equation:

graphic file with name pt4c00293_m007.jpg 7

where Ku(T) is the unfolding equilibrium constant at temperature T.

A linear equation of best fit of ΔGu(T) versus temperature corresponding to 10–50% of unfolding enables the calculation of free energy (ΔGu(To)), entropy (ΔSu(To)), and enthalpy (ΔHu(To)) of unfolding in the absence of ligand.26 The values of the regression coefficient (R2) should be greater than 0.9 to indicate reliable values of these thermodynamic parameters. It should be noted that this linear fit implicitely assumes ΔCpu(To) is zero (i.e., ΔHu(To) is independent of temperature); this assumption holds when the temperature range is small.

The midpoint transition temperatures in the absence (To) and presence of ligand (Tm) were then calculated using eq 2. Finally, the values of ΔHu(To), ΔCpu(To)=0, To and Tm were used to calculate the dissociation constant (Kd(Tm)) at Tm using eq 3.

Unfolding Equilibrium Constant (UEC) Method

The advantage of this method over the previous two is that it does not require calculation of the thermodynamic parameters ΔHu(To) and ΔCpu(To) to determine the dissociation constant at the protein’s melting temperature Kd(To). The equation can be derived by modifying the equation presented by Brandts and Lin, 1990 as follows (Figure 1).12

Figure 1.

Figure 1

Determination of the unfolding equilibrium constant in the presence of ligand Keq(To) from the sigmoidal unfolding curves. To is the temperature at the midpoint of the protein unfolding transition in the absence of ligand. Qu and Qf are the fractions of unfolded and folded protein.

Let P represent the folded and P′ represent the unfolded form of the protein. For the reaction P⇌P′, the expression for the unfolding constant, K(T) = [P′]/[P], can be rearranged to give

graphic file with name pt4c00293_m008.jpg 8

Assuming that ligand L binds only to the folded form of the protein,12 the expression for the binding constant can be written as

KL(T) = [PL]/[P][L], which can be rearranged to give

graphic file with name pt4c00293_m009.jpg 9

The unfolding constant in the presence of ligand, K(eq)(T) can be written as

graphic file with name pt4c00293_m010.jpg 10

Since at the protein’s melting temperature To, K(To) = 1, we can write

graphic file with name pt4c00293_m011.jpg 11

which can be rearranged to give an expression for the dissociation constant Kd at To

graphic file with name pt4c00293_m012.jpg 12

The Keq(To) can be determined directly from the experimental data as shown in Figure 1, with Qu and Qf calculated using eqs 4 and (5). Again, the following approximations can be made: [L]To = [L]total/2 when [L]total < [P]total, [L]To = [L]total – [P]total/2 when [L]total ≥ [P]total12 and [L]To ≈ [L]total when [L]total ≫ [P]total.6 Substituting the values of Keq(To) and [L]To in eq 12 enables the calculation of the binding affinity at To, Kd(To).

Calculation of Dissociation Constant at Other Temperatures (T)

The dissociation constant at temperature T (Kd(T)) can be obtained from the dissociation constant at Tm (Kd(Tm)) using the following equation:12

graphic file with name pt4c00293_m013.jpg 13

where ΔHL(T) is the enthalpy of ligand binding (also known as van’t Hoff enthalpy of binding) at temperature T and ΔCpL is the molar heat capacity change due to ligand binding. The binding enthalpy can be measured using ITC, but when unknown, previous studies suggested to use values ranging from −5.0 to −15.0 kcal mol–1.6,27,28 Here, we compared calculations using the values of −15.0 kcal mol–1, −5.0 kcal mol–1, the enthalpy obtained from ITC, or the enthalpy estimated using the average enthalpy efficiencies of ligand atoms.

If ΔCpL is not known, the approximate Kd(T) can be calculated using the following simplified equation:6

graphic file with name pt4c00293_m014.jpg 14

Calculation of Molar Heat Capacity Change of Ligand Binding (ΔCpL)

The molar heat capacity change due to ligand binding (ΔCpL) was calculated based on the crystal structures of free and/or ligand-bound proteins (PDB IDs: 4XMR, 6W3S, 6W3T, 6W3X, 6Q0F, 6PXY, 6PY5, 6PY4, 5WBF, and 6OFQ)1821,29 by following the method described in Baker and Murphy 1998.30 Any missing residues were modeled using the MODELER comparative modeling software.31 The accessible surface areas (ASA) were calculated using the NACCESS program.32 For each structure, 20 models were generated, and the average ASA was used to compute the ΔCpL.

The molar heat capacity change due to ligand binding (ΔCpL) was calculated from the difference in apolar (ΔASAap) and polar (ΔASApol) accessible surface areas upon ligand binding (ΔASA = ASA(ligand-bound) – ASA(ligand-free) – ASA(ligand)) using the following equation:30

graphic file with name pt4c00293_m015.jpg 15

with the empirical parameters Δcp,ap and Δcp,pol set at 1.82 and −1.09, respectively.

It should be noted that in cases where there is evidence of coupling of multiple equilibria, connecting multiple protein conformations, the observed apparent association constant is the population weighted average of the intrinsic association constants for each reaction.33,34 Among the four proteins studied here, the TSA of Tlp3 showed the presence of multiple conformations, which became less pronounced upon the addition of ligand (Supplementary Figure 1), indicating that binding of the ligand is only weakly coupled to the conformational equilibrium or conformational changes. In such instances, it is reasonable to assume a ΔCpL of −300 cal mol–1 K–1 at room temperature.34

Enthalpy of Ligand Binding (ΔHL(T))

The enthalpy of ligand binding (ΔHL(T)) was determined using the average enthalpy efficiencies of −0.66, −0.33, and −0.13 kcal mol–1 per heavy (non-hydrogen) atom for heavy atom counts of 0–19, 20–39, and 40–77, respectively, as described in Reynolds and Holloway 2011.35 The calculated ΔHL(T) values for the ligands used in this study are provided in Table 1.

Table 1. Enthalpies of Ligand Binding (ΔHL(T)) Estimated from Average Enthalpy Efficiencies.

Ligand Number of Heavy Atoms ΔHL(T) (kcal mol–1)
l-Isoleucine 9 –5.94
l-Leucine 9 –5.94
l-Valine 8 –5.28
l-Norvaline 8 –5.28
l-Alanine 6 –3.96
l-Serine 7 –4.62
l-Lactate 6 –3.96
Ser-Thr-Ser-Ala (STSA) 25 –8.25

Effect of Approximation of Free Ligand Concentration on the Accuracy of Binding Affinity

The concentration of free ligand at the protein’s melting temperature ([L]To) was approximated to the total ligand concentration ([L]total) when [L]total ≥ [P]total. To evaluate the impact of this approximation on the binding affinities of Tlp3-Ile and CtaA-Ser interactions, we calculated the free ligand concentration at the protein’s melting temperature using the following equation:12

graphic file with name pt4c00293_0009.jpg 16

The binding affinities of Tlp3-Ile (over a ligand concentration range of 0.1 mM to 20 mM) and CtaA-Ser interactions (over a ligand concentration range of 10 μM to 70 μM) at the protein’s melting temperature (Kd(To)) were calculated using the binding affinity (Kd(25 °C) and enthalpy of binding (ΔHL(25 °C)) obtained from ITC (as shown in Table 1 for Kd(To) and Table 2 for ΔHL(25 °C)). The UEC method was employed to calculate Kd(To), assuming that ΔHL(25 °C) remains invariant over the small temperature range.

Table 2. Midpoint Transition Temperatures in the Presence of Ligand (Tm) and Dissociation Constants at Tm (Kd(Tm)) and/or To (Kd(To)).

      Dissociation Constant at Tm, Kd(Tm) (μM)
Dissociation Constant at To, Kd(To) (μM)
Ligand Protein Midpoint Transition Temperature in Presence of Ligand, Tm (K) CF ZHC Using Data from ITCa,b UEC Using Data from ITCa,b
l-Isoleucine Tlp3 337.6 ± 0.3 1728 ± 384 711 ± 147 630 ± 62 705 ± 205 530 ± 62
l-Leucine Tlp3 337.3 ± 0.2 2164 ± 411 875 ± 152 799 ± 38 949 ± 182 676 ± 32
l-Norvaline Tlp3 336.8 ± 0.3 3805 ± 1495 1424 ± 470 1762 ± 47 1584 ± 671 1532 ± 82
l-Valine Tlp3 337.7 ± 0.3 5099 ± 1291 2116 ± 505 3055 ± 267 2291 ± 534 2495 ± 166
l-Valine CtaA 330.7 ± 0.2 0.5 ± 0.1 4.0 ± 0.4 4 ± 1 2.5 ± 0.4 4 ± 1
l-Alanine CtaA 329.2 ± 0.1 2.0 ± 0.2 8.9 ± 0.6 7.4 ± 0.4 5 ± 1 7.1 ± 0.4
l-Serine CtaA 328.2 ± 0.3 4.9 ± 1.3 18 ± 4 13 ± 1 6 ± 3 12 ± 1
l-Leucine CtaA 327.8 ± 0.3 7.4 ± 1.9 26 ± 7 10 ± 2 11 ± 3 10 ± 2
l-Lactate TlpC 320.4 ± 0.2 213 ± 28 581 ± 54 2062 ± 11 250 ± 87 1081 ± 8
STSA DppA 344.5 ± 0.4 10 ± 2 34 ± 5 140 ± 12 29 ± 2 89 ± 9
a

Using enthalpy of binding (ΔHL) from ITC (Table 3)

b

Using molar heat capacity change of binding (ΔCpL) from Table 3.

Results

We employed three distinct approaches to determine protein–ligand binding affinities by a thermal shift assay: curve fitting (CF), zero heat capacity change assumption (ZHC), and unfolding equilibrium constant (UEC) method. All three methods are applicable to single-transition protein unfolding data. The traditional CF method enables the calculation of the protein unfolding enthalpy (ΔHu(To)), molar heat capacity change (ΔCpu(To)), and melting temperature in the absence of ligand (To) by fitting the experimental data to equation 1. The ZHC method assumes that the molar heat capacity change due to unfolding (ΔCpu(To)) is zero, and estimates ΔHu(To) using the unfolding equilibrium constant. In both methods, the melting temperature in the presence of ligand (Tm) is then obtained by fitting the fluorescence intensity data to the Boltzmann sigmoid equation 2, and the binding affinity at the melting temperature in the presence of ligand (Kd(Tm)) is determined by substituting the calculated parameters into equation 3. In contrast, the third method, UEC, has an advantage in that these thermodynamic parameters are not required for calculating the binding affinity at the protein’s melting temperature (Kd(To)). Instead, the UEC method utilizes the unfolding equilibrium constant in the presence of ligand to directly calculate Kd(To).

The dissociation constants at the melting temperature obtained using the CF, ZHC and UEC methods were then converted into the dissociation constants at 25 °C (Kd(T)). For CtaA, TlpC and DppA, the molar heat capacity change due to ligand binding (ΔCpL) was calculated from the crystal structures of the respective complexes. In the case of Tlp3, which exists in multiple conformational states in solution, and where ligand binding only weakly impacts on the conformational equilibrium, an assumed ΔCpL value of −300 cal mol–1 K–1 was used.34 To assess the quantitative agreement with the binding affinities obtained from ITC, we calculated the mean relative deviation (MRD) as the mean of (|(Kd determined using TSA) – (Kd determined from ITC)|/(Kd determined from ITC)) for each method.

Dissociation Constant Calculations Using the Curve Fitting (CF) Approach

Determination of the thermal unfolding parameters (To, ΔHu(To), ΔCpu(To)) for the proteins in the absence of ligands using the CF method yielded the following values: (To = 321.2 ± 0.6 K, ΔHu(To) = −95 ± 3 kcal mol–1, ΔCpu(To) = 13.5 ± 0.9 kcal mol–1 K–1) for Tlp3; (To = 311.0 ± 2.2 K, ΔHu(To) = −116 ± 15 kcal mol–1, ΔCpu(To) = 15.9 ± 1.5 kcal mol–1 K–1) for CtaA; (To = 300.0 ± 1.9 K, ΔHu(To) = −62 ± 12 kcal mol–1, ΔCpu(To) = 9.6 ± 0.5 kcal mol–1 K–1) for TlpC; and (To = 319.6 ± 7.6 K, ΔHu(To) = −26 ± 33 kcal mol–1, ΔCpu(To) = 4.4 ± 0.5 kcal mol–1 K–1) for DppA. The midpoint transition temperatures in the presence of ligand Tm and the dissociation constants at Tm (Kd(Tm)) calculated using the CF method (equation 3) are presented in Table 2.

It is clear from above that the To for CtaA and TlpC are very low (near or below to the experimental temperature range), this is a limitation of the curve fitting method in accurately and reliably estimating To (and potentially ΔHu and ΔCpu) while attempting to fit experimental data to equation 1 without bias. In this method, there are three unknown variables (To, ΔHu(To), and ΔCpu(To)) that must be calculated by fitting the experimental data to equation 1. Due to the presence of multiple unknowns in the equation, there exist numerous combinations of these variables if biases, such as imposing restrictions on To or ΔHu(To) or ΔCpu(To) to be greater than or less than or equal to certain values, are introduced during the calculation process. This is a common challenge encountered when dealing with equations containing multiple unknowns. Researchers often perform the fitting process while keeping certain variables fixed at assumed values, thereby introducing bias into the calculations (even though the exact values of these variables are unknown)5,36 or obtain those values by performing DSC experiments.22 Therefore, the calculation of unfolding energies using the CF method may be flawed due to these inherent challenges.

The dissociation constants at Tm (Kd(Tm)) were converted to dissociation constants at 25 °C (Kd(T)) shown in Table 3. Table 3 also illustrates that the enthalpy of ligand binding (ΔHL(T)), required for this conversion, can be measured experimentally (e.g., using ITC), calculated from the average enthalpy efficiencies of non-hydrogen atoms of the ligand, or given an assumed value (−15 kcal mol–1 or −5 kcal mol–1). For each method to obtain ΔHL(T), we assessed the agreement with the binding affinities Kd(T) obtained from ITC by calculating the MRDs of Kd. The MRD values were 0.83 for ΔHL(T) = −15 kcal mol–1, 0.97 for ΔHL(T) = −5 kcal mol–1, 0.87 for ΔHL(T) calculated from the average enthalpy efficiencies, and 0.97 for the ΔHL(T) obtained from ITC.

Table 3. Dissociation Constants at 25 °C (Kd(T)) Calculated by the Curve Fitting (CF) Method Using Assumed, Calculated, or Measured Values for Enthalpies of Binding ΔHL(T).

      Curve Fitting (CF) Method (Kd(T) μM)
 
          ΔHL(T) Calculated from the Average Enthalpy Efficiencies
ΔHL(T) from ITC
 
Protein–Ligand Complex Ligand Concentration Molar Heat Capacity Change due to Ligand Binding (ΔCpL, cal K–1 mol–1) ΔHL(T) = −15 kcal mol–1 ΔHL(T) = −5 kcal mol–1 kcal mol–1 Kd(T) (μM) kcal mol–1 Kd(T) (μM) Kd(T) from ITC (μM)
Tlp3-Ile 3 mM –300 29 ± 7 209 ± 50 –5.94 174 ± 42 –4.40 235 ± 57 86 ± 1018
Tlp3-Leu 3 mM –300 37 ± 9 267 ± 59 –5.94 222 ± 49 –4.60 288 ± 64 105 ± 629
Tlp3-Nva 3 mM –300 70 ± 30 489 ± 204 –5.28 463 ± 194 –6.50 365 ± 153 168 ± 929
Tlp3-Val 10 mM –300 84 ± 24 611 ± 167 –5.28 578 ± 158 –4.40 688 ± 188 405 ± 2729
CtaA-Val 20 μM –44 0.03 ± 0.01 0.18 ± 0.04 –5.28 0.2 ± 0 1.70 0.6 ± 0.1 4.7 ± 1.219
CtaA-Ala 20 μM –17 0.17 ± 0.02 0.8 ± 0.1 –3.96 1.0 ± 0.1 –1.91 1.4 ± 0.1 5.2 ± 0.319
CtaA-Ser 20 μM 2 0.5 ± 0.1 2.3 ± 0.6 –4.62 2.4 ± 0.7 –1.85 4 ± 1 9.5 ± 1.119
CtaA-Leu 20 μM –60 0.7 ± 0.2 3.0 ± 0.8 –5.94 2.6 ± 0.7 1.90 9 ± 2 11.9 ± 1.819
TlpC-lactate 7.5 mM –54 34 ± 5 110 ± 15 –3.96 124 ± 17 –21.32 16 ± 2 155 ± 520
DppA-STSA 200 μM –95 0.20 ± 0.04 1.9 ± 0.3 –8.25 0.9 ± 0.2 –11.80 0.4 ± 0.1 5.9 ± 0.621

Dissociation Constant Calculations Using the Zero Heat Capacity Change (ZHC) Approach

The enthalpies of unfolding (ΔHu(To)) of free Tlp3, CtaA, TlpC, and DppA were determined using the ZHC method. Figure 2 illustrates fitting data to a linear equation representing the relationship between the Gibbs free energy of unfolding ΔGu and temperature T in the range corresponding to 10–50% unfolding. The high values of the regression coefficient R2 (greater than 0.9) indicate the methodology is suitable for estimating the thermodynamic parameters for these proteins.26

Figure 2.

Figure 2

Line of best fit representing the relationship between the Gibbs free energy of unfolding ΔGu and temperature in the range corresponding to 10–50% of unfolding for (A) 10 μM Tlp3, (B) 5 μM CtaA, (C) 20 μM TlpC, and (D) 10 μM DppA in the absence of ligand.

Determination of the thermal unfolding parameters for the proteins in the absence of ligands using the ZHC method yielded the following values: (To = 335.0 ± 0.3 K, ΔHu(To) = 148 ± 7 kcal mol–1, ΔCpu(To) = 0 kcal K–1 mol–1)) for Tlp3; (To = 326.4 ± 0.4 K, ΔHu(To) = 84 ± 17 kcal mol–1, ΔCpu(To) = 0 cal K–1 mol–1) for CtaA; (To = 314.6 ± 0.4 K, ΔHu(To) = 91 ± 3 kcal mol–1, ΔCpu(To) = 0 kcal K–1 mol–1) for TlpC; and (To = 337.9 ± 0.4 K, ΔHu(To) = 68 ± 4 kcal mol–1, ΔCpu(To) = 0 kcal K–1 mol–1) for DppA.

The dissociation constants at Tm (Kd(Tm)) calculated using the ZHC method are presented in Table 2. These values were converted to dissociation constants at 25 °C (Kd(T)) shown in Table 4. Table 4 allows direct comparison of the dissociation constants measured by ITC and derived by the ZHC method using different assumptions for the enthalpy of ligand binding (ΔHL(T)). To quantify the agreement between the ITC- and ZHC method-derived values for each assumption about enthalpy, we calculated the MRDs of Kd. The MRD values were 0.82 for ΔHL(T) = −15 kcal mol–1, 0.28 for ΔHL(T) = −5 kcal mol–1, 0.36 for ΔHL(T) calculated from the average enthalpy efficiencies, and 0.44 for the ΔHL(T) obtained from ITC.

Table 4. Dissociation Constants at 25 °C (Kd(T)) Calculated by the Zero Heat Capacity Change (ZHC) Method Using Assumed, Calculated, or Measured Values for Enthalpies of Binding ΔHL(T).

      Zero Heat Capacity Change (ZHC) Method (Kd(T), μM)
 
          ΔHL(T) Calculated from the Average Enthalpy Efficiencies
ΔHL(T) from ITC
 
Protein–Ligand Complex Ligand Concentration Molar Heat Capacity Change due to Ligand Binding (ΔCpL, cal K–1 mol–1) ΔHL(T) = −15 kcal mol–1 ΔHL(T) = −5 kcal mol–1 kcal mol–1 Kd(T) (μM) kcal mol–1 Kd(T) (μM) Kd(T) from ITC (μM)
Tlp3-Ile 3 mM –300 12 ± 3 86 ± 19 –5.94 71 ± 16 –4.40 97 ± 22 86 ± 1018
Tlp3-Leu 3 mM –300 15 ± 3 108 ± 22 –5.94 90 ± 18 –4.60 117 ± 24 105 ± 629
Tlp3-Nva 3 mM –300 26 ± 10 183 ± 65 –5.28 173 ± 62 –6.50 137 ± 49 168 ± 929
Tlp3-Val 10 mM –300 35 ± 10 253 ± 66 –5.28 240 ± 62 –4.40 285 ± 74 405 ± 2729
CtaA-Val 20 μM –44 0.29 ± 0.03 1.5 ± 0.2 –5.28 1.5 ± 0.2 1.70 4.7 ± 0.5 4.7 ± 1.219
CtaA-Ala 20 μM –17 0.8 ± 0.1 3.9 ± 0.3 –3.96 4.6 ± 0.3 –1.91 6.3 ± 0.4 5.2 ± 0.319
CtaA-Ser 20 μM 2 1.7 ± 0.4 8 ± 2 –4.62 9 ± 2 –1.85 13 ± 3 9.5 ± 1.119
CtaA-Leu 20 μM –60 2.3 ± 0.6 11 ± 3 –5.94 9 ± 2 1.90 30 ± 8 11.9 ± 1.819
TlpC-lactate 7.5 mM –54 92 ± 10 301 ± 30 –3.96 340 ± 33 –21.32 44 ± 5 155 ± 520
DppA-STSA 200 μM –95 0.7 ± 0.1 6.8 ± 1.1 –8.25 3.2 ± 0.6 –11.80 1.4 ± 0.3 5.9 ± 0.621

Dissociation Constant Calculations Using the Unfolding Equilibrium Constant (UEC) Approach

In the UEC method, the thermal unfolding parameters ΔHu(To) and ΔCpu(To) are not required. Instead, the dissociation constant at the protein’s melting temperature (Kd(To)) is calculated from the value of the unfolding equilibrium constant in the presence of ligand at To (K(eq)(To)), determined directly from the unfolding curves as shown in Figure 1. The Kd(To) values calculated for all analyzed protein–ligand pairs using the UEC method are shown in Table 2. The dissociation constant values calculated at 25 °C (Kd(T)) are shown in Table 5. This table allows a direct, side-by-side comparison of the dissociation constants measured by ITC and derived by the UEC method using different assumptions for the enthalpy of ligand binding (ΔHL(T)). The calculated MRD values of ITC- and UEC method-derived Kd values were 0.84 for ΔHL(T) = −15 kcal mol–1, 0.40 for ΔHL(T) = −5 kcal mol–1, 0.34 for ΔHL(T) calculated from the average enthalpy efficiencies, and 0.37 for the ΔHL(T) obtained from ITC.

Table 5. Dissociation Constants at 25 °C (Kd(T)) Calculated by Unfolding Equilibrium Constant (UEC) Method Using Assumed, Calculated, or Measured Values for Enthalpies of Binding ΔHL(T).

      Unfolding Equilibrium Constant (UEC) Method (Kd(T) μM)
 
          ΔHL(T) Calculated from the Average Enthalpy Efficiencies
ΔHL(T) from ITC
 
Protein–Ligand Complex Ligand Concentration Molar Heat Capacity Change due to Ligand Binding (ΔCpL, cal K–1 mol–1) ΔHL(T) = −15 kcal mol–1 ΔHL(T) = −5 kcal mol–1 kcal mol–1 Kd(T) (μM) kcal mol–1 Kd(T) (μM) Kd(T) from ITC (μM)
Tlp3-Ile 3 mM –300 16 ± 5 102 ± 30 –5.94 86 ± 25 –4.40 115 ± 33 86 ± 1018
Tlp3-Leu 3 mM –300 21 ± 4 138 ± 27 –5.94 116 ± 23 –4.60 148 ± 29 105 ± 629
Tlp3-Nva 3 mM –300 36 ± 15 230 ± 97 –5.28 218 ± 92 –6.50 174 ± 74 168 ± 929
Tlp3-Val 10 mM –300 51 ± 12 333 ± 78 –5.28 316 ± 74 –4.40 372 ± 87 405 ± 2729
CtaA-Val 20 μM –44 0.25 ± 0.04 1.1 ± 0.2 –5.28 1.2 ± 0.2 1.70 3.0 ± 0.5 4.7 ± 1.219
CtaA-Ala 20 μM –17 0.6 ± 0.1 2.4 ± 0.5 –3.96 3.2 ± 0.6 –1.91 3.8 ± 0.7 5.2 ± 0.319
CtaA-Ser 20 μM 2 0.7 ± 0.3 3 ± 1 –4.62 4 ± 2 –1.85 5 ± 2 9.5 ± 1.119
CtaA-Leu 20 μM –60 1.1 ± 0.3 5 ± 1 –5.94 5 ± 1 1.90 13 ± 3 11.9 ± 1.819
TlpC-lactate 7.5 mM –54 63 ± 22 154 ± 53 –3.96 169 ± 59 –21.32 36 ± 12 155 ± 520
DppA-STSA 200 μM –95 1.0 ± 0.1 7.4 ± 0.6 –8.25 3.9 ± 0.3 –11.80 1.9 ± 0.1 5.9 ± 0.621

Analysis and Comparison of the Accuracy of the Three Methods Using a Single Ligand Concentration

To compare the accuracy of determination of the binding affinity at the melting temperature by the three methods, we calculated the MRDs between TSA- and ITC-derived Kd using data presented in Table 2. The MRD values for the ZHC and UEC methods (0.43 and 0.35, respectively) were markedly lower than that for the CF method (0.96), indicating that the ZHC and UEC methods introduced in this study provide significantly more accurate estimates of the binding affinities at the protein’s melting temperature compared to the CF method. Since all three methods use the same temperature conversion equation for Kd (equation 13), the accuracy of the Kd values calculated by the ZHC and UEC methods at 25 °C was also significantly higher than for the CF method, as demonstrated by the lower listed MRD values at 25 °C.

To analyze how different assumptions for the enthalpy of ligand binding (ΔHL) affect the accuracy of conversion of dissociation constants at the melting temperature to dissociation constants at 25 °C, we compared the MRDs of Kd at 25 °C for each assumption. We observed that both the ZHC and UEC methods produce more reliable affinity values when the enthalpy of binding (ΔHL) is obtained from ITC, calculated from the average enthalpy efficiencies, or when an assumed ΔHL value happens to closely match that obtained from ITC experiments.

We note, however, that even when the experimentally determined ΔHL values are used (ITC), the use of the CF method resulted in substantial deviations from the experimentally determined Kd for certain protein–ligand pairs (Tlp3-Ile, CtaA-Val, CtaA-Ala, TlpC-lactate, and DppA-STSA), with the calculated Kd ranging from 3 times higher or 4 to 14 times lower than the ITC-derived values (Table 3). These deviations indicate that the CF method does not consistently provide reliable estimates of the binding affinity for all protein–ligand interactions. In contrast, as seen in Tables 4 and 5, the ZHC- and UEC-method-derived Kd values do not deviate from the ITC values by more than 2–3 fold when the ΔHL is obtained from ITC or calculated from the average enthalpy efficiencies. Given that the Kd measurements of the same interaction obtained using different experimental techniques (including differential scanning calorimetry (DSC), ITC or SPR) show some deviation and typically fall within a 2- to 3-fold range,11,3740 we conclude that both the ZHC and UEC methods produce reliable estimates of the binding affinities, and exhibit a much improved performance compared to the CF method.

Analysis of Ligand Concentration-Dependent Variations in the Calculated Binding Constants

Previously reported methods of estimation of binding affinity using TSA produced results that were strongly biased by the concentration of the ligand in the experimental setup.4 Consequently, in our investigation, we determined the dissociation constants for the Tlp3-Ile and CtaA-Ser interactions using a range of ligand concentrations and assessed concentration-dependent variability in Kd for the CF, ZHC and UEC methods. The Kd(T) values were calculated using the ΔHL(T) obtained from ITC and the ΔCPL using the crystal structures of the respective complexes. Figure 3 depicts the impact of Ile and Ser concentration on the calculated dissociation constants for Tlp3 and CtaA at 25 °C. For the Tlp3-Ile interaction, the MRDs of Kd determined using the ZHC and UEC methods (0.38 and 0.30, respectively), were significantly lower than that for the CF method (0.73). Similarly, for the CtaA-Ser interaction, the MRDs of Kd calculated using the ZHC and UEC methods (0.24 and 0.41, respectively), were considerably lower than that for the CF method (0.79). The MRD values and the data presented in Figure 3 indicate that the CF method demonstrated substantial ligand concentration-dependent variations in the calculated binding affinity, in agreement with previous literature reports.4 In comparison to the CF method, the Kd(T) values determined using the ZHC and UEC methods deviated less from the ITC-derived Kd(T) over the tested range of ligand concentrations, suggesting that the ZHC and UEC methods can produce reliable and consistent calculations of Kd over a broad range of ligand concentrations relative to the respective dissociation constants.

Figure 3.

Figure 3

Ligand concentration-dependent variations in the binding constants Kd(T) derived using the three TSA-based methods described in this study and comparison with the Kd(T) value determined using ITC for the (A) Tlp3-Ile interaction and (B) CtaA-Ser interaction.

Effect of Approximation of Free Ligand Concentration on the Accuracy of Binding Affinity

The comparison of Kd(T) values calculated using [L]To and [L]total for Tlp3-Ile and CtaA-Ser interactions is presented in Figure 4. The mean deviation, defined as the average of the absolute differences between Kd(T) values determined using [L]To and those determined using [L]total, was 0.23 μM for Tlp3-Ile and 0.32 μM for CtaA-Ser. The low mean deviation values indicate that the approximation of the free ligand concentration ([L]To) has no substantial impact on the accuracy of the calculated binding affinities.

Figure 4.

Figure 4

Effect of approximation of free ligand concentration on the accuracy of binding affinity derived using the UEC method and comparison with the Kd(T) value for (A) the Tlp3-Ile interaction and (B) the CtaA-Ser interaction.

Conversion of Binding Affinities Determined at Melting Temperature to Room Temperature Values when ΔHL(T) and ΔCPL Are Unknown

As the final step of our analysis, we considered how our new method can be applied to high-throughput screening for potential binders. To model this scenario, we assumed that neither the crystal structures nor ITC measurements for enthalpy of binding (ΔHL(T)) were available. With regards to the molar heat capacity change value (ΔCpL), we tested and compared two assumptions; first, we used the simplified equation 14, assuming that the equation 13 term containing ΔCpL is negligibly small, as proposed by Pantoliano et al., 2001.6 Second, we assumed that ΔCpL is −300 cal mol–1 K–1 at room temperature.34 With regards to the enthalpy of binding (ΔHL(T)), we compared calculations using either the presumed ΔHL values of −5 kcal mol–1 or −15 kcal mol–1,4,6,22,36 or values calculated from the average enthalpy efficiencies of non-hydrogen atoms of the ligand.35

We employed the UEC method and these assumptions to calculate Kd(T) from the values determined at melting temperature (Table 2) using the full equation 13, or its simplified version (14). Analysis of the results presented in Figure 5 showed that, in many cases, using equation 13 with ΔCpL = −300 cal K–1 mol–1 and either ΔHL(T) = −5 kcal mol–1 or ΔHL(T) calculated from average enthalpy efficiencies provided more reliable Kd(T) estimates compared to the simplified equation 14. Therefore, in the context of high-throughput drug screening, when ΔHL and ΔCPL are unknown, and calculation of ΔHL from average enthalpy efficiencies for hundreds or thousands of library compounds may be not practical, we recommend employing the full equation (equation 13), assuming ΔCpL = −300 cal K–1 mol–1 and ΔHL(T) = −5 kcal mol–1.

Figure 5.

Figure 5

Comparison of the binding affinities at 25 °C calculated using the unfolding equilibrium constant (UEC) method when the enthalpy and molar heat capacity change of binding are unknown and are assigned assumed values. The experimentally determined value (ITC) is also shown as a reference point.

Discussion

The thermal shift assay (TSA) has emerged as a cost-effective, parallelizable, simple, and fast technique for assessing protein stability and ligand binding affinity. In contrast to circular dichroism spectroscopy, DSC, SPR, NMR and ITC, TSA can be easily conducted using standard real-time PCR instruments or fluorescence plate readers. Furthermore, the assay requires relatively small amounts of protein, and is therefore compatible with high-throughput screening and suitable for large-scale studies.

TSA has been widely employed in diverse research areas, including lead compound screening for target proteins6,8 and protein buffer optimization.7,8 Recent studies have brought into the spotlight its potential as a method for determination of protein–ligand binding affinities.911 However, many of the previously reported methods require measurements over a range of ligand concentrations to accurately estimate binding affinity.911 Here, we introduced two novel approaches that allow reliable determination of binding affinity from TSA data collected for a single ligand concentration. The simplification of the process should allow implementation of these methods for screening of drug-like molecules, that is typically performed using libraries of molecules at one fixed concentration. This would significantly reduce resource requirements and enhance the efficiency of the drug discovery workflow.

Our results demonstrate that the CF approach, extensively employed thus far for estimating Kd from TSA data,4,6,22 yielded values that significantly deviate from the values determined through ITC. In contrast, the newly introduced ZHC and UEC methods of Kd determination introduced in this work demonstrated close agreement with the values obtained from ITC. This is reflected in the mean relative deviation (MRD) from the ITC-derived Kd for the CF method (0.96) being significantly higher than those for the ZHC and UEC methods (0.43 and 0.35). Furthermore, our analysis demonstrates that while the Kd calculations using the CF method produced significant ligand concentration-dependent variations, the calculations based on the ZHC and UEC methods were stable over the tested range of ligand concentrations. This suggests that the ZHC and UEC methods can generate reliable estimations of Kd regardless of the specific ligand concentration used.

The ZHC approach uses the same equation and thermal unfolding parameters (To, ΔHu(To) and ΔCpu(To)) for the calculation of the binding affinity as the CF method. However, the calculation of ΔHu(To) is improved by employing a recently reported technique,26 where we assume that the molar heat capacity change due to unfolding, ΔCpu(To), is zero. On the other hand, the UEC approach offers an advantage over the previous two methods in that it does not require the calculation of the thermal unfolding parameters ΔHu(To) and ΔCpu(To) to determine the binding affinity. Instead, the UEC method calculates the binding affinity using the unfolding equilibrium constant derived directly from the fluorescence intensity data. This simplifies the process by reducing the number of calculations.

It needs to be noted that the analysis of the TSA data allows the calculation of Kd at the protein’s melting temperature, and this value then needs to be converted to Kd at the physiologically relevant temperature. In this study, we evaluated different ways of conversion to 25 °C, because the referenced ITC experiments were performed at that temperature. However, the same approach can be applied to convert to any temperature that reflects the native protein environment (to gauge the strength of protein–ligand interactions in vivo), or that was used to measure Kd using a different method (to compare results for consistency).

To accurately convert the binding affinity to other temperatures using equation 13, one requires the knowledge of the thermodynamic parameters such as enthalpy (ΔHL(T)) and molar heat capacity change of ligand binding (ΔCpL). Although the enthalpy of binding can be experimentally measured using ITC or DSC, (for example Lo et al. 2004;4 Matulis et al. 2005;36 Linkuvienė et al. 202211), the challenges associated with these methods, including lack of high-throughput, are well recognized. To circumvent this limitation, various studies proposed to use different assumed values for ΔHL(T), ranging from −5.0 to −15.0 kcal mol–1. This variation in the suggested values highlights the lack of consensus in the field and the need for an accessible method to estimate this value. To address this need, our methodology integrated a straightforward estimation of the enthalpy using the average enthalpy efficiencies of ligand atoms. Our analysis demonstrated that both the ZHC and UEC methods generate more accurate affinity values when the enthalpy of binding is derived from ITC, calculated from the average enthalpy efficiencies, or when an assumed ΔHL value is close to that obtained from ITC experiments. In addition, we observed that when one cannot estimate the molar heat capacity change of ligand binding (ΔCpL) (from e.g. a crystal structure of the complex), using an assumed value of −300 cal K–1 mol–1 for the ΔCpL provides better binding affinity estimates compared to the approximated equation that negates the ΔCpL term altogether (equation 14). Based on our findings, if no specific information about ΔHL(T) and ΔCpL is available, assuming a value of −300 cal K–1 mol–1 for ΔCpL, and either −5 kcal mol–1 or the average enthalpy efficiencies-based estimation for ΔHL(T) can still provide reasonable estimates of the binding affinity.

When considering TSA for high-throughput screening, one needs to note that the technique is not suitable for hydrophobic proteins or fluorescent ligands due to potential high background fluorescence. Additionally, buffers with high heat capacity should be avoided.4,7 The temperature range should be chosen based on the transition temperature (Tm) of the protein under investigation; in this study, a range of 35 to 85 °C was used because all tested proteins had Tm values exceeding 50 °C.

The ligand concentration in high-throughput TSA screening for potential binders is an important parameter to consider and optimize. By using a ligand concentration of at least 1–2 times the estimated dissociation constant (Kd), one would ensure that there is sufficient binding to detect and measure. At the same time, one would want to avoid using a concentration that is so high that it exceeds solubility limits, resulting in aggregation that can interfere with the assay. Additionally, some small molecules, when used as high concentrations, quench the fluorescence of the dye used in the assay.6 It has been suggested that it may be optimal to use high-throughput screening libraries with the ligand concentration of 25 μM or less.6 Using this concentration for screening would mean that hits with Kd greater than ∼25 μM may not be detected, but these weaker binders are typically disregarded anyway in favor of more potent ones.6

Conclusion

The thermal shift assay (TSA) has emerged as a powerful tool for determination of the binding affinity (Kd) of protein–ligand interactions. Its broad applicability, simplicity, speed, cost-effectiveness and high-throughput capability make it a favored choice for drug discovery. Implementation of the new approaches described in our study would significantly enhance the efficiency of TSA by providing accurate binding affinity measurements from data collected for a single ligand concentration, reducing experimental complexity, and enabling streamlined drug discovery efforts. However, it is important to note that our developed method was applied to a set of ligands with limited chemical diversity. Therefore, further experimental studies with ligands of varying chemical nature are necessary to validate and extend the applicability of our approach.

Acknowledgments

We would like to thank Christopher MacRaild (Monash University) for helpful comments on the manuscript. The described project was supported by the NIH National Institutes of Allergy and Infectious Disease grant RO1AI116946 to K.M.O.

Data Availability Statement

All data are included in the article and in the Supporting Information.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsptsci.4c00293.

  • Fluorescence intensity data of proteins undergoing thermal unfolding in the presence or absence of ligands (PDF)

Author Contributions

M.F.K.: Designed and performed research, contributed new analytic tools, analyzed data, Writing–original draft. M.M.R.: Performed research. Y.X.: Performed research. A.M.: Analyzed data. B.J.S.: Funding acquisition, analyzed data, Writing–review and editing. K.M.O.: Funding acquisition, Writing–review and editing. A.R.: Designed research, Funding acquisition, Analyzed data, Supervision, Writing–review and editing.

The authors declare no competing financial interest.

Supplementary Material

pt4c00293_si_001.pdf (787.5KB, pdf)

References

  1. Chandel T. I.; Zaman M.; Khan M. V.; Ali M.; Rabbani G.; Ishtikhar M.; Khan R. H. A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and inhibition of protein aggregates: An overview. Int. J. Biol. Macromol. 2018, 106, 1115–1129. 10.1016/j.ijbiomac.2017.07.185. [DOI] [PubMed] [Google Scholar]
  2. Linkuviene V.; Talibov V. O.; Danielson U. H.; Matulis D. Introduction of intrinsic kinetics of protein-ligand interactions and their implications for drug design. J. Med. Chem. 2018, 61 (6), 2292–2302. 10.1021/acs.jmedchem.7b01408. [DOI] [PubMed] [Google Scholar]
  3. Fu Y.; Zhao J.; Chen Z. Insights into the molecular mechanisms of protein-ligand interactions by molecular docking and molecular dynamics simulation: a case of oligopeptide binding protein. Comput. Math. Methods Med. 2018, 2018 (1), 3502514. 10.1155/2018/3502514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lo M.-C.; Aulabaugh A.; Jin G.; Cowling R.; Bard J.; Malamas M.; Ellestad G. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal. Biochem. 2004, 332 (1), 153–159. 10.1016/j.ab.2004.04.031. [DOI] [PubMed] [Google Scholar]
  5. Cimmperman P.; Baranauskienė L.; Jachimovičiu̅tė S.; Jachno J.; Torresan J.; Michailovienė V.; Matulienė J.; Sereikaitė J.; Bumelis V.; Matulis D. A quantitative model of thermal stabilization and destabilization of proteins by ligands. Biophys. J. 2008, 95 (7), 3222–3231. 10.1529/biophysj.108.134973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Pantoliano M. W.; Petrella E. C.; Kwasnoski J. D.; Lobanov V. S.; Myslik J.; Graf E.; Carver T.; Asel E.; Springer B. A.; Lane P. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J. Biomol. Screen. 2001, 6 (6), 429–440. 10.1177/108705710100600609. [DOI] [PubMed] [Google Scholar]
  7. Huynh K.; Partch C. L. Analysis of protein stability and ligand interactions by thermal shift assay. Curr. Protoc. Protein Sci. 2015, 79 (1), 28.29.21–28.29.14. 10.1002/0471140864.ps2809s79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gao K.; Oerlemans R.; Groves M. R. Theory and applications of differential scanning fluorimetry in early-stage drug discovery. Biophys. Rev. 2020, 12 (1), 85–104. 10.1007/s12551-020-00619-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bai N.; Roder H.; Dickson A.; Karanicolas J. Isothermal analysis of ThermoFluor data can readily provide quantitative binding affinities. Sci. Rep. 2019, 9 (1), 2650. 10.1038/s41598-018-37072-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Niebling S.; Burastero O.; Bürgi J.; Günther C.; Defelipe L. A.; Sander S.; Gattkowski E.; Anjanappa R.; Wilmanns M.; Springer S. FoldAffinity: binding affinities from nDSF experiments. Sci. Rep. 2021, 11 (1), 9572. 10.1038/s41598-021-88985-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Linkuvienė V.; Zubrienė A.; Matulis D. Intrinsic affinity of protein-ligand binding by differential scanning calorimetry. Biochim. Biophys. Acta - Proteins Proteom. 2022, 1870 (9), 140830. 10.1016/j.bbapap.2022.140830. [DOI] [PubMed] [Google Scholar]
  12. Brandts J. F.; Lin L. N. Study of strong to ultratight protein interactions using differential scanning calorimetry. Biochem. 1990, 29 (29), 6927–6940. 10.1021/bi00481a024. [DOI] [PubMed] [Google Scholar]
  13. Krainer G.; Keller S. Single-experiment displacement assay for quantifying high-affinity binding by isothermal titration calorimetry. Methods 2015, 76, 116–123. 10.1016/j.ymeth.2014.10.034. [DOI] [PubMed] [Google Scholar]
  14. Dalvit C.; Gmür I.; Rößler P.; Gossert A. D. Affinity measurement of strong ligands with NMR spectroscopy: Limitations and ways to overcome them. Prog. Nucl. Magn. Reson. Spectrosc. 2023, 138-139, 52. 10.1016/j.pnmrs.2023.07.001. [DOI] [PubMed] [Google Scholar]
  15. Lundblad J. R.; Laurance M.; Goodman R. H. Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Molecular endocrinology 1996, 10 (6), 607–612. 10.1210/mend.10.6.8776720. [DOI] [PubMed] [Google Scholar]
  16. LiCata V. J.; Wowor A. J. Applications of fluorescence anisotropy to the study of protein-DNA interactions. Methods in cell biology 2008, 84, 243–262. 10.1016/S0091-679X(07)84009-X. [DOI] [PubMed] [Google Scholar]
  17. Rahman H.; King R. M.; Shewell L. K.; Semchenko E. A.; Hartley-Tassell L. E.; Wilson J. C.; Day C. J.; Korolik V. Characterisation of a multi-ligand binding chemoreceptor CcmL (Tlp3) of Campylobacter jejuni. PLoS pathog. 2014, 10 (1), e1003822 10.1371/journal.ppat.1003822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Liu Y. C.; Machuca M. A.; Beckham S. A.; Gunzburg M. J.; Roujeinikova A. Structural basis for amino-acid recognition and transmembrane signalling by tandem Per-Arnt-Sim (tandem PAS) chemoreceptor sensory domains. Acta Crystallogr. D Biol. Crystallogr. 2015, 71 (10), 2127–2136. 10.1107/S139900471501384X. [DOI] [PubMed] [Google Scholar]
  19. Ud-Din A. I.; Khan M. F.; Roujeinikova A. Broad specificity of amino acid chemoreceptor CtaA of Pseudomonas fluorescens is afforded by plasticity of its amphipathic ligand-binding pocket. Plant. Microbe. Interact. 2020, 33 (4), 612–623. 10.1094/MPMI-10-19-0277-R. [DOI] [PubMed] [Google Scholar]
  20. Machuca M. A.; Johnson K. S.; Liu Y. C.; Steer D. L.; Ottemann K. M.; Roujeinikova A. Helicobacter pylori chemoreceptor TlpC mediates chemotaxis to lactate. Sci. Rep. 2017, 7 (1), 14089. 10.1038/s41598-017-14372-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rahman M. M.; Machuca M. A.; Khan M. F.; Barlow C. K.; Schittenhelm R. B.; Roujeinikova A. Molecular basis of unexpected specificity of ABC transporter-associated substrate-binding protein DppA from Helicobacter pylori. J. Bacteriol. 2019, 201 (20), e00400–e00419. 10.1128/JB.00400-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Afanador G. A.; Muench S. P.; McPhillie M.; Fomovska A.; Schön A.; Zhou Y.; Cheng G.; Stec J.; Freundlich J. S.; Shieh H.-M. Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay. Biochem. 2013, 52 (51), 9155–9166. 10.1021/bi400945y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Machuca M. A.; Liu Y. C.; Beckham S. A.; Roujeinikova A. Cloning, refolding, purification and preliminary crystallographic analysis of the sensory domain of the Campylobacter chemoreceptor for multiple ligands (CcmL). Acta Crystallogr. F: Struct. Biol. Commun. 2015, 71 (2), 211–216. 10.1107/S2053230X1500045X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ud-Din A. I. M. S.; Roujeinikova A. Cloning, purification, crystallization and X-ray crystallographic analysis of the periplasmic sensing domain of Pseudomonas fluorescens chemotactic transducer of amino acids type A (CtaA). Biosci. Trends 2016, 10 (4), 320–324. 10.5582/bst.2016.01059. [DOI] [PubMed] [Google Scholar]
  25. Liu Y. C.; Roujeinikova A. Expression, refolding, purification and crystallization of the sensory domain of the TlpC chemoreceptor from Helicobacter pylori for structural studies. Protein Expr. Purif. 2015, 107, 29–34. 10.1016/j.pep.2014.11.003. [DOI] [PubMed] [Google Scholar]
  26. Wright T. A.; Stewart J. M.; Page R. C.; Konkolewicz D. Extraction of Thermodynamic Parameters of Protein Unfolding Using Parallelized Differential Scanning Fluorimetry. J. Phys. Chem. Lett. 2017, 8 (3), 553–558. 10.1021/acs.jpclett.6b02894. [DOI] [PubMed] [Google Scholar]
  27. Biltonen R.; Langerman N.. Microcalorimetry for biological chemistry: Experimental design, data analysis, and interpretation. In Methods in Enzymology; Elsevier, 1979; Vol. 61, pp 287–318; 10.1016/0076-6879(79)61016-9. [DOI] [PubMed] [Google Scholar]
  28. Wiseman T.; Williston S.; Brandts J. F.; Lin L.-N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 1989, 179 (1), 131–137. 10.1016/0003-2697(89)90213-3. [DOI] [PubMed] [Google Scholar]
  29. Khan M. F.; Machuca M. A.; Rahman M. M.; Koç C.; Norton R. S.; Smith B. J.; Roujeinikova A. Structure-activity relationship study reveals the molecular basis for specific sensing of hydrophobic amino acids by the Campylobacter jejuni chemoreceptor Tlp3. Biomolecules 2020, 10 (5), 744. 10.3390/biom10050744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Baker B. M.; Murphy K. P. Prediction of binding energetics from structure using empirical parameterization. Methods enzymol. 1998, 295, 294–315. 10.1016/S0076-6879(98)95045-5. [DOI] [PubMed] [Google Scholar]
  31. Webb B.; Sali A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinformatics. 2016, 54 (1), 5.6.1–5.6.37. 10.1002/cpbi.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hubbard S.; Thornton J. M.. NACCESS Computer Program; Department of Biochemistry and Molecular Biology, University College: London, 1993. [Google Scholar]
  33. Prabhu N. V.; Sharp K. A. Heat capacity in proteins. Annu. Rev. Phys. Chem. 2005, 56, 521–548. 10.1146/annurev.physchem.56.092503.141202. [DOI] [PubMed] [Google Scholar]
  34. Vega S.; Abian O.; Velazquez-Campoy A. On the link between conformational changes, ligand binding and heat capacity. Biochim. Biophys. Acta. Gen. Subj. 2016, 1860 (5), 868–878. 10.1016/j.bbagen.2015.10.010. [DOI] [PubMed] [Google Scholar]
  35. Reynolds C. H.; Holloway M. K. Thermodynamics of ligand binding and efficiency. ACS Med. Chem. Lett. 2011, 2 (6), 433–437. 10.1021/ml200010k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Matulis D.; Kranz J. K.; Salemme F. R.; Todd M. J. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochem. 2005, 44 (13), 5258–5266. 10.1021/bi048135v. [DOI] [PubMed] [Google Scholar]
  37. Linkuvienė V.; Zubrienė A.; Manakova E.; Petrauskas V.; Baranauskienė L.; Zakšauskas A.; Smirnov A.; Gražulis S.; Ladbury J. E.; Matulis D. Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design. Q. Rev. Biophys. 2018, 51, e10 10.1017/S0033583518000082. [DOI] [PubMed] [Google Scholar]
  38. Paketurytė V.; Linkuvienė V.; Krainer G.; Chen W.-Y.; Matulis D. Repeatability, precision, and accuracy of the enthalpies and Gibbs energies of a protein-ligand binding reaction measured by isothermal titration calorimetry. Eur. Biophys. J. 2019, 48, 139–152. 10.1007/s00249-018-1341-z. [DOI] [PubMed] [Google Scholar]
  39. Paketurytė V.; Petrauskas V.; Zubrienė A.; Abian O.; Bastos M.; Chen W.-Y.; Moreno M. J.; Krainer G.; Linkuvienė V.; Sedivy A. Uncertainty in protein-ligand binding constants: Asymmetric confidence intervals versus standard errors. Eur. Biophys. J. 2021, 50 (3–4), 661–670. 10.1007/s00249-021-01518-4. [DOI] [PubMed] [Google Scholar]
  40. Linkuvienė V.; Krainer G.; Chen W.-Y.; Matulis D. Isothermal titration calorimetry for drug design: Precision of the enthalpy and binding constant measurements and comparison of the instruments. Anal. Biochem. 2016, 515, 61–64. 10.1016/j.ab.2016.10.005. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

pt4c00293_si_001.pdf (787.5KB, pdf)

Data Availability Statement

All data are included in the article and in the Supporting Information.


Articles from ACS Pharmacology & Translational Science are provided here courtesy of American Chemical Society

RESOURCES